Sign in
4

Changes in Ownership

Whitehawk Therapeutics, Inc. Filed Acc 0000899243-18-010750

Options or other derivatives

  • Chief Scientific Officer acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

PETERS KEVIN G. · Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-04-23 Grant or award : show line 1 in the form Stock Option (Right to Buy) +100,000 100,000 D
Loading xslF345X03/doc4.xml…